Showing posts with label biotechnology. Show all posts
Showing posts with label biotechnology. Show all posts

Tuesday, February 18, 2020

What is Epigenetics, and why is Epigenetics market important?

Industry Analysis of “Epigenetics” Market
This extensive analysis sheds light on an array of intangible aspects connected with the business such as important definitions, end use and total revenue garnered across different regions. The researcher has taken a conscious effort to get a closer look at some of the top performers of the Epigenetics industry. Other essential aspects evaluated during research include import and export, demand and supply, distribution channel, gross margin and supply chain management. To add more credibility to the research the study examines the winning strategies adopted by the prominent vendors to maintain competitive edge worldwide. Vital statistics on the business performance is projected using self-explanatory resources charts, tables and graphic images

Market Size – USD 7.10 billion in 2018, Market Growth - CAGR of 13.1%, Market Trends– Rising prevalence of cancer and other chronic diseases, and increased research funding
Have Queries? To request a sample or speak to an expert before you buy the report, click on the link below: https://www.reportsanddata.com/sample-enquiry-form/2079
This study relies on the evolution of the industry to derive the trends that are observed. A significant increase in the global market is visible, which promises the expansion of the market in the coming years.
The report focuses on the emerging sectors of the industry and their potential impact on the growth of the market in the forecasted duration. It highlights the concentration of the consumer bases of key companies geographically and the contribution of these companies to the regional economy. The study gives a historical analysis to draw the prospective growth of the market size, share, trends, overall earnings, gross revenue, and net value. It provides a detailed outlook of the market along with expert insights to assist the readers in their investments.
The following Top manufacturers are assessed in this report:
JM Eagle, Chevron Phillips Chemical Company, Aliaxis, WL Plastics, Jain Irrigation Systems, Pipelife International, Nandi Group, Blue Diamond Industries, ADS, National Pipe & Plastics, Kubota-C.I., FLO-TEK, Olayan Group, Pexmart, Godavari Polymers, LESSO
The report on global Epigenetics market is intended to offer business owners, stakeholders and field marketing executives a broad overview of the business they should be focusing on for the estimated period. The research further holds vital information on the size of market and data on the prominent leaders’ product owners have to compete with, in the coming years. Assessments of the broad strengths, as well as weaknesses too, add value to the overall research. Products details not only cover the popular applications and its performance, but it also unveils certain trends and value of specific products within specific regions.
Vital statistics associated with the sudden shift in the customer preference, production capability; region-wise sale, profit and total revenue are showcased through detailed charts, tables and graphic images.
To Ask About Report Discount, Availability or Customization, Visit here: https://www.reportsanddata.com/discount-enquiry-form/2079
Product Type Outlook (Revenue in USD Million; 2016–2026)
  • Reagents
  • Kits
  • Chip sequencing kit
  • Whole Genomic Amplification kit
  • Bisulfite Conversion kit
  • RNA sequencing kit
  • Others
  • Instruments
  • Enzymes
  • Services
Technology Outlook (Revenue in USD Million; 2016–2026)
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large non - coding RNA
  • MicroRNA modification
  • Chromatin structures
Application Outlook (Revenue in USD Million; 2016–2026)
  • Oncology
  • Solid tumors                       
  • Liquid tumors
  • Non - oncology
  • Inflammatory diseases
  • Metabolic diseases
  • Infectious diseases
  • Cardiovascular diseases
  • Others
End Use Outlook (Revenue in Million USD; 2016–2026)
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
The industry experts have left no stone unturned to identify the major factors influencing the development rate of the Epigenetics industry including various opportunities and gaps. A thorough analysis of the micro markets with regards to the growth trends in each category makes the overall study interesting. When studying the micro markets the researchers also dig deep into their future prospect and contribution to the Epigenetics industry.
The market intelligence report combines the best of both bottom-up as well as top-down techniques to verify and predict the growth of the Epigenetics industry worldwide. While assessing the global size of the industry, researchers also examine the dependent submarkets.
The research comprises of an extensive application of qualitative and quantitative methods to identify the impact of technological developments in the field and options available in the Epigenetics business.
Key Coverage of the Report
Region and country-wise assessment from the period 2016-2026. For the study, 2016-2017 has been utilized as historical data, 2018 as the base year, and 2019-2026, has been derived as forecasts for the Epigenetics market.
Regional Competitors pipeline analysis.
Demand and Supply GAP Analysis.
Market share analysis of the key industry players.
Strategic recommendations for the new entrants.
Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets.
Industry Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations).
Strategic recommendations in key business segments based on the market estimations.
Competitive landscaping mapping the key common trends.
Company profiling with detailed strategies, financials, and recent developments.
Get to know the business better:
The global Epigenetics market research is carried out at the different stages of the business lifecycle from the production of a product, cost, launch, application, consumption volume and sale. The research offers valuable insights into the marketplace from the beginning including some sound business plans chalked out by prominent market leaders to establish a strong foothold and expand their products into one that’s better than others.
Any special requirements about this report, please let us know and we can provide custom report.
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail:
sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com

Friday, November 22, 2019

Mycoplasma Testing Market Growth, Types, Application and Forecasts to 2026

Market Size – USD 541.2 Million in 2018, Market Growth - CAGR of 12.6%, Market Trends – Growing awareness and cost and time effective diagnosis.
According to the current analysis of Reports and Data, the global Mycoplasma Testing market was valued at USD 541.2 million in 2018 and is expected to reach USD 1.42 million by year 2026, at a CAGR of 12.6%. Mycoplasma is the smallest discovered species of bacteria, mostly developed through the de-generative evolution from Gram-positive bacteria. Mycoplasma bacterial cell lacks a cell wall and can either be parasitic or saprotrophic. Though, there are around 200 different types of mycoplasma bacteria, most of them are harmless. Only 5 out of 200 cause severe infections in humans, which include Mycoplasma pneumonia, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. Different species of mycoplasma cause different diseases in the human body. For example, Mycoplasma pneumonia affects the throat and lungs, while Mycoplasma genitalium is associated with urethra infection.

To Access PDF Sample Report, With 30 mins free consultation! Click Here: https://www.reportsanddata.com/sample-enquiry-form/2129
Mycoplasma Testing Market | Reports and Data
Mycoplasma testing is used to diagnose present or past mycoplasma infection in patients. Mycoplasma microbes can exist as healthy flora in the patient’s throat, genitourinary tract, or respiratory tract. Additionally, due to the lack of cell wall, the mycoplasma bacterial cells are immune to a several common antibiotics. Furthermore, mycoplasma testing plays an essential role in cell culture and must be done at every step of product development, including cell banks, viral seed stocks, and final products. The mycoplasma testing market is majorly driven by significant research and development activities in academia as well as the bio-pharmaceutical industry, increasing incidences of mycoplasma infections, and cell culture contamination. Mycoplasma can quickly spread through droplets during cell culture and are difficult to detect under a microscope; hence, they need specific tests to be performed for the same. 
Growing expenditure in the healthcare sector by key market players to enhance customer satisfaction and achieve technological advancements is  expected to propel the global market for mycoplasma testing.  Mycoplasma testing market is also driven by the increased adoption of mycoplasma testing in the microbiology sector, rising occurrences of mycoplasma infections, growing number of water pollution-related infections, favorable investment scenario for the healthcare industry through public and private sector, and increasing awareness about mycoplasma bacterial infections. However, lack of awareness of mycoplasma infection among patients & clinicians, and challenges related to its detection are expected to hinder the market growth. ,
Further key findings from the report suggest
  • Mycoplasma testing market is growing at a CAGR of 13.0% in Asia Pacific, followed by North America and Europe, with 12.8 % and 12.5% CAGR respectively. Increasing government support, coupled with high investments in R&D, is a major factor driving the market growth.
  • As of 2018, Kits & Reagents segment is the dominating Mycoplasma testing, which holds 47.5% of the global market. The Asia Pacific regional market is the chief revenue generating source for this product segment, followed by the North American and European regions.
  • Mycoplasma infection is one of the major cause of human infectious diseases, therefore the sample requires to be tested at every step of processing.
  • The absence of a cell wall allows the mycoplasma bacteria to enter the white blood corpuscles (WBCs), which makes it almost impossible to kill these bacteria once they hide in the immune system.
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/mycoplasma-testing-market
  • As mycoplasma infection can become chronic, it reduces the efficiency and strength of the immune system, making it weak over time and highly increasing the risk of infections caused by other microorganisms.
  • Mycoplasma contamination is the most common but serious problem faced while culturing cells, thus proper mycoplasma testing should be carried out before production of the final product. For instance, the MycoProbe Mycoplasma Detection Kit can be used for high-throughput and routine screening of cell culture for detection of mycoplasma contamination.
  • Key participants include Thermo Fisher Scientific Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Norgen Biotek Corp. (Canada), GenBio (Canada), Meridian Bioscience, Inc. (U.S.), and Savyon Diagnostics (Israel).
For the purpose of this report, Reports and Data has segmented the mycoplasma testing market on the basis of product type, technology type, application type, end use, and region:
Product Type (Revenue, USD Million; 2016–2026)
  • Instruments
  • Kits & Reagents
    • PCR Assay
    • Nucleic Acid Detection
    • Elimination Kits & Reagent
    • Stains
    • Standards & Controls
    • Others
  • Services
  • Others
Technology Type (Revenue, USD Million; 2016–2026)
  • PCR
  • ELISA
  • Direct Assay
  • Indirect Assay
  • DNA Staining
  • Microbial Culture Techniques
  • Enzymatic Methods
  • Others
Application Type (Revenue, USD Million; 2016–2026)
  • Cell Line Testing
  • Virus Testing
  • End of Production Cells Testing
  • Others
End Use (Revenue, USD Million; 2016–2026)
  • Pharmaceutical Companies
  • Cell Banks
  • Others
Grab Your Report at an Impressive Discount! Please click Here@ https://www.reportsanddata.com/discount-enquiry-form/2129
Regional Outlook (Revenue in USD Million; 2016–2026)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John Watson
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports  and Data | Web: www.reportsanddata.com
News: www.reportsanddata.com/market-news


Wednesday, June 19, 2019

Cerebrospinal Fluid (CSF) Management Market Size, Status, Share And Forecast By 2026


The Cerebrospinal Fluid Management market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids.
One of the biggest limitations is the inability to produce in the required amount of time a sufficient number of trained neurosurgeons. This lack of trained neurochirurgical professionals extends to North America, Europe, Asia Pacific, Latin America, and Africa.
Further key findings from the report suggest
  • The Cerebrospinal Fluid Management market was valued at USD 1.45 Billion in 2018 and is expected to reach USD 2.11 Billion by 2026, at a CAGR of 4.7% during the forecast period. The increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide are key factors driving the growth of the market for managing cerebrospinal fluids.
  • The market for hospitals is expected to grow the largest and is estimated to reach at USD 781.5 Million in 2026, at a CAGR of 5.4%, owing to large number of in-hospital cases related to cerebrospinal fluid management in elderly population. The market for Ambulatory Surgical Centers and Diagnostic Centers is expected to grow at the highest CAGR of 6.1% during the forecast period owing to the low cost in relation with surgery in the facility.
  • The key players in the market are Dispomedica (Germany), Sophysa (France), Spiegelberg GmbH (Germany), Medtronic plc (Ireland), Integra LifeSciences (US), B. Braun (Germany), DePuy Synthes (US), Argi Grup (Turkey), Moller Medical (Germany), Sophysa (France and others.
Segments covered in the report:
This report forecasts volume and revenue growth at a global, regional & country level, and provides an analysis on the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the market on the basis of types, end use, patient type and regional analysis.
Types (Revenue, USD Million; 2016-2026)
  • Shunts
    • Ventriculoperitoneal Shunts
    • Ventriculoatrial Shunts
    • Lumboperitoneal Shunts
    • Ventriculopleural Shunts
    • Fixed Valve Shunts
    • Adjustable Valve Shunts
  • External Drainage Systems
    • External Ventricular Drainage Systems
    • Lumbar Drainage Systems
End Use (Revenue, USD Million; 2016-2026)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Patient Type (Revenue, USD Million; 2016-2026)
  • Pediatric
  • Adult
  • Geriatric
Region (Thousand, Units and Revenue, USD Million; 2016-2026)
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa

The Alarming Increase in Incidences of Stroke is Boosting the Adoption of Neurovascular Devices

Neurovascular disorders are the second most leading causes of death worldwide after heart diseases. Statistical data suggest a high number o...